Skip to Main Content

Paper Details

Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations.
Urol Oncol
3
2023
Author NameAffiliation
Stuart R LipsitzCenter for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School
Timothy R RebbeckDana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health
Joel S WeissmanCenter for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School
Toni K ChoueiriLank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
  • 1 - 4

Datasets